Adult ADHD and psychosis: A review of the literature and two cases

Clinical Neuropsychiatry

Volumn 6, Issue 4, 2009, Pages 174-178

  Sambhi, Rajvinder Singh ^a   Lepping, Peter ^a,b  

^a BETSI CADWALADR UNIVERSITY HEALTH BOARD   (United Kingdom)

^b BANGOR UNIVERSITY   (United Kingdom)

Author keywords

Antipsychotics; Attention deficit hyperactivity disorder (ADHD); Psychiatric conditions; Psychostimulants

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; METHYLPHENIDATE; QUETIAPINE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; AUDITORY HALLUCINATION; BEDTIME DOSAGE; BORDERLINE STATE; CASE REPORT; COMORBIDITY; DELUSION; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FOLLOW UP; HUMAN; HYPERACTIVITY; MALE; ONSET AGE; PATIENT ASSESSMENT; PATIENT COMPLIANCE; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; RATING SCALE; SEDATION; SIDE EFFECT; SYMPTOM; TASK PERFORMANCE; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 74849116439     PISSN: 17244935     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Asherson P (2005). Clinical assessment and treatment of attention deficit hyperactivity disorder in adults. Expert Rev Neurother 5, 525-39.
2. Asherson P et al. (2007). Adult attention-deficit hyperactivity disorder: recognition and treatment in general adult psychiatry. Br J Psychiatry 190, 4-5.
3. Bellak L, Kay S, Opler L (1987). ADD psychosis as a diagnostic category. Psychiatry Dev 3, 239-263.
4. Berman SM, Kuczenski R, McCracken JT, London ED (2009). Potential adverse effects of amphetamine treatment on brain and behaviour: a review. Mol Psychiatry 14, 2, 123-42.
5. Biederman J, Hammerness P, Doyle R et al. (2008). Risperidone treatment for ADHD in children and adolescents with bipolar disorder. Neuropsychiatric Disease and Treatment 4, 1, 203-207.
6. Greiner C, Enß E, Haen E (2008). [Drug-Induced Psychosis after Intake of a Modified - Release Formulation of Methylphenidate.] Psychiatr Prax May 27.
7. Huber M, Kirchler E, Niederhofer H et al. (2007). Neuropsychiatric bases of the methylphenidate therapy of the attention deficit/hyperactivity disorder ADHD. Fortschr Neurol Psychiatr 75, 5, 275-84.
8. Huey L, Zetin M, Janowsky D (1978). Adult minimal brain dysfunction and schizophrenia: a case report. Am J of Psychiatry 135, 1563-1565.
9. Kessler RC, Adler L, Barkley R, et al. (2006). The Prevalence and Correlates of Adult ADHD in the United States: Results from the National Comorbidity Survey Replication. Am J Psychiatry 163, 716-723,
10. Kronenberger et al. (2007). Quetiapine addition in adolescents with methylphenidate treatment-resistant co morbid ADHD, conduct/oppositional defiant disorder and aggression: a prospective open-label study. Journal of Child and Adolescent Psychopharmacology 17, 3, 334-347.
11. Kurlan R, Como PG, Miller B, et al. (2002). The behavioural spectrum of tic disorders Neurology 59, 414-420.
12. McCarthy S, Asherson P, Coghill D, et al. (2009). Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults. Br J Psychiatry 194, 273-277.
13. National Institute of Clinical Excellence Guidelines (2008): Diagnosis and management of ADHD in children, young people and adults National Clinical Practice Guideline Number 72 : www.nice.org.uk
14. Opler LA, Frank DM, Ramirez PM (2001). Psycho stimulants in the treatment of Adults with Psychosis and Attention Deficit Disorder. Annals New York Academy of Sciences 297-301.
15. Pine DS, Klein RG, Lindy DC, et al. (1993). Attention-deficit hyperactivity disorder and co morbid psychosis: a review and two clinical presentations. J Clin Psychiatry 54, 140-145.
16. Rösler M, Retz W, Retz-Junginger P, et al. (2004). Prevalence of attention deficit-/hyperactivity disorder (ADHD) and co morbid disorders in young male prison inmates. Eur Arch Psychiatry Clin Neurosci 254, 6, 365-71.
17. Rösler M, Retz W, Yaqoobi K, et al. (2009). Attention deficit/hyperactivity disorder in female offenders: prevalence, psychiatric co morbidity and psychosocial implications. Eur Arch Psychiatry Clin Neurosci 259, 2, 98-105.
18. Simon V, Bitter I. Czobor P, et al. (2009). Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry 194, 3, 204-11.
19. Tossell JW, Greenstein DK, Davidson AL, et al. (2004). Stimulant Drug Treatment in Childhood-Onset Schizophrenia with Comorbid ADHD: An Open-Label Case Series. Journal of Child and Adolescent Psychopharmacology 14, 3, 448-454.
20. Wilens TE, Faraone SV, Biederman J (2004). Attention-deficit hyperactivity disorder in adults. JAMA 292, 619-623.